
Alkem Laboratories (ALKEM) Share Price Falls 2.05% as Large Cap Pharma Stock Trades at Rs 5,250
Updated: 8 Oct 2026 • 1:06 pm
Posted by:

Alkem Laboratories Share Price was under pressure in the latest session, with the stock trading at Rs 5,250 after a 2.05% decline. The company’s market capitalisation stood at Rs 62,925.86 crore, keeping Alkem Laboratories Share Price firmly in the large cap category. For investors tracking Alkem Laboratories Share Price Today, the move is notable because the stock opened at Rs 5,400.05, touched the same level as its day high, and then moved down to a day low of Rs 5,250. Univest figures confirm the price action, but they do not point to a specific company trigger. That makes the focus shift to Alkem Laboratories Share Price, valuation ratios and Healthcare sector context rather than a single visible trigger.
Alkem Laboratories Stock News, as seen through today’s price action, is therefore about the decline itself and the metrics around it. The latest Univest figures show that investors watching Alkem Laboratories Share Price Live can use today’s move as a reference point for broader Alkem Laboratories Stock Analysis and Alkem Laboratories Fundamental Analysis.
Alkem Laboratories (ALKEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,250 |
| Previous Close | Rs 5,360 |
| Today's Move | -Rs 110.00 (-2.05%) |
| Open | Rs 5,400.05 |
| High | Rs 5,400.05 |
| Low | Rs 5,250 |
| Market Capitalisation | Rs 62,925.86 crore |
| Market Cap Category | Large Cap |
Alkem Laboratories Share Price Today reflects a clean intraday decline rather than a prolonged streak, because the stock has fallen in the latest session only. The previous close was Rs 5,360, and the stock last traded at Rs 5,250, down Rs 110 or 2.05%. The day open and day high were both Rs 5,400.05, while the day low was Rs 5,250, which means Alkem Laboratories Share Price moved from the opening level and stayed within that narrow band. The market capitalisation of Rs 62,925.86 crore places Alkem Laboratories Share Price in the large cap bucket, which is important for company-size context. For readers following Alkem Laboratories Share Price Update or Alkem Laboratories Share Price Fall, the move shows a lower intraday level relative to the prior session’s close without requiring any extra explanation beyond the verified figures.
That is the core of Alkem Laboratories Share Price Today: a lower quote, a defined open-high-low structure and a large cap profile. The next step is to assess whether Alkem Laboratories Fundamental Analysis supports the current market attention.
Alkem Laboratories (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 62,925.86 crore |
| P/E Ratio | 29.7x |
| P/B Ratio | 4.48x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 0.99% |
Alkem Laboratories (ALKEM) fundamental metrics show P/E 29.7x, P/B 4.48x, ROE 18.29%, ROCE 21.28%. Taken on their own, these numbers offer context rather than a trading signal.
Alkem Laboratories has a market capitalisation of Rs 62,925.86 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.7x, P/B at 4.48x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 180.45, book value per share of Rs 1,196.51, dividend yield of 0.99%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.7x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 4.48x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 62,925.86 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Alkem Laboratories (ALKEM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Alkem Laboratories (ALKEM) has a P/E ratio of 29.7x, which is below the benchmark median of 31.87x, a difference of -6.81%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Alkem Laboratories (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.61%, a difference of +57.54%. Alkem Laboratories (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.46%, a difference of +58.1%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
Alkem Laboratories (ALKEM) has a P/E ratio of 29.7x compared with the displayed peer median of 82.14x. The comparison is relative and should not be read as a recommendation. Its ROE of 18.29% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Alkem Laboratories (ALKEM) has a market capitalisation of Rs 62,925.86 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Alkem Laboratories
- Alkem Laboratories Share Price fell 2.05% in the latest session, keeping today’s move in focus.
- Alkem Laboratories Share Price Today sits at Rs 5,250 after trading between Rs 5,250 and Rs 5,400.05.
- Alkem Laboratories Fundamental Analysis shows P/E, P/B, ROE, ROCE, EPS and book value that can be compared with peers.
- Alkem Laboratories Share Price is in the large cap category, with market capitalisation of Rs 62,925.86 crore.
- Alkem Laboratories Stock News can be read against Healthcare and Pharmaceuticals & Drugs benchmark data from Univest.
About Alkem Laboratories
Alkem Laboratories operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is part of the large cap segment and is tracked by investors for its position within Indian pharma. Alkem Laboratories Share Price moves are typically read alongside its earnings profile, profitability ratios and valuation multiples. In the context of Alkem Laboratories Stock Analysis, the company’s business belongs to a sector where return ratios, pricing power and peer comparisons often matter as much as the daily share price move. That makes Alkem Laboratories Share Price relevant not only as a market quote but also as a reflection of its business profile in a competitive drug and healthcare universe.
Track Alkem Laboratories Share Price on Univest
Use Alkem Laboratories (ALKEM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Alkem Laboratories Share Price on Univest for live updates, key valuation ratios, 52-week levels and market insights. Alkem Laboratories Share Price Today can also be reviewed alongside peer comparisons, company context and Healthcare sector benchmarks. For readers following Alkem Laboratories Latest News, Univest brings the stock price, fundamental ratios and company-level context into one view without adding noise.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Alkem Laboratories Share Price fall today?
Ans. Alkem Laboratories Share Price fell 2.05% to Rs 5,250 in the latest session. Univest figures confirm the price action, but they do not point to a specific company trigger. The previous close was Rs 5,360.
What is Alkem Laboratories Share Price today?
Ans. Alkem Laboratories Share Price was last traded at Rs 5,250, down Rs 110 from the previous close of Rs 5,360. The stock opened at Rs 5,400.05 and touched a day low of Rs 5,250.
Is Alkem Laboratories a large cap stock?
Ans. Yes. Alkem Laboratories Share Price is linked to a large cap company with market capitalisation of Rs 62,925.86 crore. That size context helps place today’s decline within the broader Healthcare universe.
What is the valuation of Alkem Laboratories Share Price?
Ans. Alkem Laboratories Share Price is trading at a P/E of 29.7 and a P/B of 4.48. Those multiples can be compared with the same-industry benchmark and listed peers to understand relative valuation.
How do ROE and ROCE look for Alkem Laboratories?
Ans. Alkem Laboratories Share Price is supported by ROE of 18.29% and ROCE of 21.28%. Both measures are above the same-industry benchmark median and average, which gives the stock useful profitability context.
What do EPS and book value say about Alkem Laboratories Share Price?
Ans. EPS is Rs 180.45 and book value is Rs 1,196.51 per share. EPS shows earnings attributable to each share, while book value reflects accounting net worth behind each share. The previous close was Rs 5,360.
How does Alkem Laboratories compare with Healthcare peers?
Ans. Alkem Laboratories Share Price sits below Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals on market capitalisation, but its P/E is also below several richer-valued peers. That creates a mixed peer-comparison picture.
What is the dividend yield for Alkem Laboratories?
Ans. Alkem Laboratories Share Price comes with a dividend yield of 0.99%. Dividend yield is a historical payout reference relative to the current price and should be read with valuation and return ratios.
Should investors track Alkem Laboratories Share Price on Univest?
Ans. Yes. Alkem Laboratories Share Price on Univest can be followed with live price, fundamental ratios, 52-week levels and sector context. That combination helps readers monitor today’s move with verified company and industry data.
Recent Articles

ITC Share Price Dips 4% to Rs 254.70, Near Its 52-Week Low: Will It Bounce Back? Why It Fell, Q1 FY27 and Cigarette Tax Context, Brokerage Targets, Support and Stop-Loss Levels and the Risks
8 October 2026

IPO Listings Today, 8 October: Nityas Gems and Jewellery Lists at a 9% Premium and Hits the Upper Circuit While Vishal Nirmiti Lists at a 2.3% Discount, Gains and Losses Per Lot, Valuations, Subscription and What to Do Now
8 October 2026

Kriti Industries (India) (KRITI) Share Price Falls 9.61% in Latest Session
8 October 2026

Senco Gold Share Price Surges 12% After the Q2 FY27 Business Update: 31% Revenue Growth, 19% Same-Store Sales, 215 Showrooms, the Festive and Wedding Outlook, Valuation Near 9 Times Earnings and the Risks
8 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
ITC Share Price Dips 4% to Rs 254.70, Near Its 52-Week Low: Will It Bounce Back? Why It Fell, Q1 FY27 and Cigarette Tax Context, Brokerage Targets, Support and Stop-Loss Levels and the Risks
IPO Listings Today, 8 October: Nityas Gems and Jewellery Lists at a 9% Premium and Hits the Upper Circuit While Vishal Nirmiti Lists at a 2.3% Discount, Gains and Losses Per Lot, Valuations, Subscription and What to Do Now
Kriti Industries (India) (KRITI) Share Price Falls 9.61% in Latest Session
Senco Gold Share Price Surges 12% After the Q2 FY27 Business Update: 31% Revenue Growth, 19% Same-Store Sales, 215 Showrooms, the Festive and Wedding Outlook, Valuation Near 9 Times Earnings and the Risks
Lupin (LUPIN) Share Price Falls 2.02% as Large Cap Healthcare Stock Traded Near Day Low

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





